Sheng Yao, Daniel Gallenkamp, Katharina Wölfel, Bettina Lüke, Michael Schindler, Jürgen Scherkenbeck
Index: Bioorg. Med. Chem. 19 , 4669-78, (2011)
Full Text: HTML
The indole alkaloid cyclopiazonic acid (CPA) is one of the few known nanomolar inhibitors of sarco(endo)plasmic reticulum Ca²⁺-ATPase (SERCA) besides the anticancer drug thapsigargin and the antiplasmoidal terpenoid artemisinin. Due to its less complex structure CPA represents an attractive lead structure for the development of novel antimalarial drugs or for applications in the field of plant protection. We report here the first syntheses of structurally simplified CPA fragments and discuss their SERCA activities on the basis of published crystal structures of CPA-SERCA complexes.Copyright © 2011 Elsevier Ltd. All rights reserved.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
2,5-Di-tert-butylhydroquinone
CAS:88-58-4 |
C14H22O2 |
|
Discovery of novel SERCA inhibitors by virtual screening of ...
2011-05-01 [Eur. J. Med. Chem. 46 , 1512-23, (2011)] |
|
Effect of methoxychlor on Ca(2+) movement and viability in M...
2015-03-01 [Basic Clin Pharmacol Toxicol. 111(4) , 224-31, (2012)] |
|
Two distinct calcium pools in the endoplasmic reticulum of H...
2011-04-01 [Biochem. J. 435(1) , 227-35, (2011)] |
|
Effects of high-affinity inhibitors on partial reactions, ch...
2008-04-01 [Mol. Pharmacol. 73(4) , 1134-40, (2008)] |
|
Functional relevance of the de novo coupling between hTRPC1 ...
2008-04-01 [Cell. Signal. 20(4) , 737-47, (2008)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
